ALEXANDER MARGARET A.
SEC CIK 2036798 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | Pres, COO | 61.8K | $4,971 | $19.9K | 4 | 2025-01-27 | 2026-02-23 |
Most active insiders at OVID, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ALEXANDER MARGARET A. | Pres, CEO, Dir | — | $16.9K |
| 2 | Rona Jeffrey A | CBFO | — | $12.4K |
| 3 | Fitzgerald Kevin Joseph | Dir | — | — |
| 4 | Carter Charles Ross | CFO | — | — |
| 5 | Takeda Pharmaceuticals U.S.A., Inc. | 10% | — | — |
| 6 | Friedman Bart | Dir | — | — |
| 7 | LEVIN JEREMY M | Executive COB, Dir | — | — |
| 8 | PAPADOPOULOS STELIOS | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-02-23 | OVID | Ovid Therapeutics Inc. | ALEXANDER MARGARET A. | Pres, CEO, Dir | S - Sale | $1.45 | -11.7K | 61.8K | -16% | -$16.9K |
| 2025-02-28 | 2025-02-26 | OVID | Ovid Therapeutics Inc. | ALEXANDER MARGARET A. | Pres, COO | S - Sale | $0.56 | -5,279 | 73.4K | -7% | -$2,956 | |
| D | 2025-02-24 | 2025-02-20 | OVID | Ovid Therapeutics Inc. | ALEXANDER MARGARET A. | Pres, COO | A - Grant | $0.00 | +43.8K | 78.7K | +125% | $0 |
| 2025-01-29 | 2025-01-27 | OVID | Ovid Therapeutics Inc. | ALEXANDER MARGARET A. | Pres, COO | P - Purchase | $0.73 | +6,810 | 34.9K | +24% | +$4,971 |
Purchase Sale Sale after option exercise All abbreviations